Literature DB >> 11443872

Antibody-mediated enhancement of viral disease.

N J Sullivan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443872     DOI: 10.1007/978-3-662-05783-4_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  25 in total

Review 1.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

2.  Dengue hemorrhagic fever in Trinidad and Tobago: a case for a conservative approach to platelet transfusion.

Authors:  Anu Sharma; Kenneth Charles; Dave Chadee; Surujpaul Teelucksingh
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

Review 3.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

Review 4.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Authors:  Lucile Warter; Ramapraba Appanna; Katja Fink
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Authors:  Candice Clay; Nathan Donart; Ndingsa Fomukong; Jennifer B Knight; Wanli Lei; Lance Price; Fletcher Hahn; Jesse Van Westrienen; Kevin S Harrod
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

Authors:  Jean-Christophe Meunier; Ronald E Engle; Kristina Faulk; Ming Zhao; Birke Bartosch; Harvey Alter; Suzanne U Emerson; Francois-Loic Cosset; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

7.  A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.

Authors:  Suzanne J F Kaptein; Tine De Burghgraeve; Mathy Froeyen; Boris Pastorino; Marijke M F Alen; Juan A Mondotte; Piet Herdewijn; Michael Jacobs; Xavier de Lamballerie; Dominique Schols; Andrea V Gamarnik; Ferenc Sztaricskai; Johan Neyts
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

8.  Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.

Authors:  Alison Wright; Michael E Lamm; Yung T Huang
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Antibody dependent enhancement of frog virus 3 infection.

Authors:  Heather E Eaton; Emily Penny; Craig R Brunetti
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

10.  Enhancement of HIV infection by cellulose sulfate.

Authors:  Wang Tao; Chris Richards; Dean Hamer
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.